Abstract:Background: Alzheimer's disease (AD) is an incurable, debilitating neurodegenerative disorder. Current biomarkers for AD diagnosis require expensive neuroimaging or invasive cerebrospinal fluid sampling, thus precluding early detection. Blood-based biomarker discovery in Alzheimer's can facilitate less-invasive, routine diagnostic tests to aid early intervention. Therefore, we propose "c-Diadem" (constrained dual-input Alzheimer's disease model), a novel deep learning classifier which incorporates KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway constraints on the input genotyping data to predict disease, i.e., mild cognitive impairment (MCI)/AD or cognitively normal (CN). SHAP (SHapley Additive exPlanations) was used to explain the model and identify novel, potential blood-based genetic markers of MCI/AD. Methods: We developed a novel constrained deep learning neural network which utilizes SNPs (single nucleotide polymorphisms) and microarray data from ADNI (Alzheimer's Disease Neuroimaging Initiative) to predict the disease status of participants, i.e., CN or with disease (MCI/AD), and identify potential blood-based biomarkers for diagnosis and intervention. The dataset contains samples from 626 participants, of which 212 are CN (average age 74.6 ± 5.4 years) and 414 patients have MCI/AD (average age 72.7 ± 7.6 years). KEGG pathway information was used to generate constraints applied to the input tensors, thus enhancing the interpretability of the model. SHAP scores were used to identify genes which could potentially serve as biomarkers for diagnosis and targets for drug development. Results: Our model's performance, with accuracy of 69% and AUC of 70% in the test dataset, is superior to previous models. The SHAP scores show that SNPs in PRKCZ, PLCB1 and ITPR2 as well as expression of HLA-DQB1, EIF1AY, HLA-DQA1, and ZFP57 have more impact on model predictions. Conclusions: In addition to predicting MCI/AD, our model has been interrogated for potential genetic biomarkers using SHAP. From our analysis, we have identified blood-based genetic markers related to Ca2+ ion release in affected regions of the brain, as well as depression. The findings from our study provides insights into disease mechanisms, and can facilitate innovation in less-invasive, cost-effective diagnostics. To the best of our knowledge, our model is the first to use pathway constraints in a multimodal neural network to identify potential genetic markers for AD.

CKG-IMC: An inductive matrix completion method enhanced by CKG and GNN for Alzheimer's disease compound-protein interactions prediction

Regional Brain Fusion: Graph Convolutional Network for Alzheimer's Disease Prediction and Analysis

AlzhCPI: A Knowledge Base for Predicting Chemical-Protein Interactions Towards Alzheimer’s Disease

Artificial intelligence assisted identification of potential tau aggregation inhibitors: ligand- and structure-based virtual screening, in silico ADME, and molecular dynamics study

KG-DTI: a Knowledge Graph Based Deep Learning Method for Drug-Target Interaction Predictions and Alzheimer's Disease Drug Repositions.

Protein-protein interaction network analysis for the identification of novel multi-target inhibitors and target miRNAs against Alzheimer's disease

Discovery of Multitarget-Directed Ligands Against Alzheimer'S Disease Through Systematic Prediction of Chemical Protein Interactions

Attention-based Cross Domain Graph Neural Network for Prediction of Drug-Drug Interactions.

KG-DTI: a knowledge graph based deep learning method for drug-target interaction predictions and Alzheimer’s disease drug repositions

Transcriptome-guided Amyloid Imaging Genetic Analysis Via a Novel Structured Sparse Learning Algorithm.

A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles

Repurposing non-pharmacological interventions for Alzheimer's disease through link prediction on biomedical literature

MLC-GCN: Multi-Level Generated Connectome Based GCN for AD Analysis

A comparative study of GNN and MLP based machine learning for the diagnosis of Alzheimer's Disease involving data synthesis

c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease

Screening Targets and Therapeutic Drugs for Alzheimer's Disease Based on Deep Learning Model and Molecular Docking

Screening Targets and Therapeutic Drugs for Alzheimer’s Disease Based on Deep Learning Model and Molecular Docking

A Comparative Study of GNN and MLP Based Machine Learning for the Diagnosis of Alzheimer’s Disease Involving Data Synthesis

Alzheimer’s Disease Knowledge Graph Enhances Knowledge Discovery and Disease Prediction

Alzheimer's Disease Knowledge Graph Enhances Knowledge Discovery and Disease Prediction

Alzheimer’s Disease Prediction Algorithm Based on De-Correlation Constraint and Multi-Modal Feature Interaction